findmyKOL
Clinical trialNCT02615067CompletedPhase 3Interventional

Study to Evaluate 99mTc-MIP-1404 SPECT/CT Imaging in Men With Biopsy Proven Low-Grade Prostate Cancer

SponsorMolecular Insight Pharmaceuticals, Inc.Enrollment531Prostate Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

45 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • Prostate Cancer Centre

    Calgary, AB, Alberta, Canada

  • Lions Gate Hospital

    North Vancouver, British Columbia, Canada

  • Cancer Care Manitoba

    Winnipeg, Manitoba, Canada

  • Cancer Care Nova Scotia

    Halifax, Nova Scotia, Canada

  • Ottawa Hospital Research Institute, University of Ottawa

    Ottawa, Ontario, Canada

  • Princess Margaret Cancer Centre

    Toronto, Ontario, Canada

  • Sunnybrook Health Sciences Centre

    Toronto, Ontario, Canada

  • Centre Hospitalier de L'Université de Montréal (chum)

    Montreal, Quebec, Canada

  • Jewish General Hospital

    Montreal, Quebec, Canada

  • Muhc

    Montreal, Quebec, Canada

  • Centre D'Imagerie Moléculaire de Sherbrooke

    Sherbrooke, Quebec, Canada

  • Hôtel-Dieu de Québec

    Québec, Canada

United States
  • City of Hope Cancer Center

    Duarte, California, United States

  • University of California, Los Angeles

    Los Angeles, California, United States

  • Va Greater Los Angeles Healthcare

    Los Angeles, California, United States

  • University of California San Francisco

    San Francisco, California, United States

  • University of Colorado Cancer Center

    Aurora, Colorado, United States

  • Yale Cancer Center

    New Haven, Connecticut, United States

  • Florida Urology Partners - Tampa Bay

    Clearwater, Florida, United States

  • Morton Plant Hospital

    Clearwater, Florida, United States

  • University of Georgia / Regents Medical Center

    Augusta, Georgia, United States

  • University of Chicago

    Chicago, Illinois, United States

  • Louisiana State University Health Science Center

    Shreveport, Louisiana, United States

  • Johns Hopkins University

    Baltimore, Maryland, United States

  • Montgomery General Hospital

    Olney, Maryland, United States

  • Lahey Clinic

    Burlington, Massachusetts, United States

  • University of Michigan

    Ann Arbor, Michigan, United States

  • University of Minnesota

    Minneapolis, Minnesota, United States

  • Mayo Clinic

    Rochester, Minnesota, United States

  • Washington University

    St Louis, Missouri, United States

  • Cooper Health System

    Camden, New Jersey, United States

  • Weill Cornell Medical College

    New York, New York, United States

  • Stony Brook University Medical Center

    Stony Brook, New York, United States

  • Northeast Urology Research

    Concord, North Carolina, United States

  • Duke University Medical Center

    Durham, North Carolina, United States

  • Cleveland Clinic

    Cleveland, Ohio, United States

  • University of Oklahoma Peggy and Charles Stephenson Cancer Center

    Oklahoma City, Oklahoma, United States

  • Urologic Consultants of Southeastern Pa, Llp

    Bala-Cynwyd, Pennsylvania, United States

  • Thomas Jefferson University

    Philadelphia, Pennsylvania, United States

  • University of Pennsylvania

    Philadelphia, Pennsylvania, United States

5 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Dec 2015
Primary completion
28 Dec 2017
Completion
28 Dec 2017
Last update posted
10 Apr 2019
Registered enrollment
531
Registry id
NCT02615067

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.